Phase II/III Randomized Clinical Trial of Booster Dose of COVID-19 (Recombinant, Inactivated) Vaccine

NCT05354024 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

4400

Enrollment

OTHER_GOV

Sponsor class

Conditions

Coronavirus Infections
Healthy

Interventions

BIOLOGICAL: NDV-HXP-S 10μg
BIOLOGICAL: BNT162b2 30μg

Sponsor

Butantan Institute